文献速递临床试验与 GCP基础与转化研究

血流限制抗阻训练在肝硬化中的随机对照试验研究方案

Resistance training combined with blood flow restriction in cirrhosis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-05-29

本研究为随机对照试验方案,拟纳入30例肝硬化患者,随机分为血流限制抗阻训练组(BFR-RT)与对照组,评估12周训练及24周随访对肌力、肌肉量、功能表现、生活质量与跌倒风险的影响。BFR-RT组每周2次膝关节伸展训练(1×30次+3×15次,20%1-RM,50%血流闭塞压)。主要比较组内与组间效应量及最小临床重要差异。

要点

  • 首个在肝硬化患者中评估血流限制抗阻训练对神经肌肉参数影响的试验。
  • 干预为12周、每周2次膝关节伸展训练,强度20%1-RM、50%血流闭塞压。
  • 结局涵盖肌力、肌肉量、功能表现、生活质量与跌倒风险评分。

核心结论

  • 该试验旨在验证BFR-RT对肝硬化患者肌力、肌肉量、功能表现、生活质量及跌倒风险的效果,为首个此类研究。

研究设计与样本

  • 随机对照试验方案,30例肝硬化患者随机分为BFR-RT组与对照组。
  • 评估时间点为基线(0周)、12周训练后及24周随访。

关键数值与推荐

  • BFR-RT组进行12周膝关节伸展训练,每周2次,方案为1×30次及3×15次,强度20%1-RM,血流闭塞压50%。
  • 评估变量包括Child-Pugh分级、MELD评分、SF-36问卷、疲劳严重程度指数、6分钟步行试验、计时起立行走、30秒坐立试验、饮食记录、1-RM膝伸展力量及股外侧肌横截面积、羽状角、肌束长度。

临床怎么用

  • 若证实有效,BFR-RT可作为肝硬化患者改善肌肉功能与生活质量的康复干预选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients affected by hepatic cirrhosis show reductions in muscle mass and function, with poor quality of life and functional performance. As such, resistance training with blood flow restriction (BFR-RT) could be a useful therapeutic tool for health promotion. Thus, we aim to verify the effects of this intervention on muscle strength, muscle mass, fiber Pennation angle, fascicle length, functional performance, quality of life, and fall risk scores in this population. METHODS: Thirty participants will be randomly distributed between 1) BFR-RT and 2) control (CTRL). Assessments will occur at three time points: before the training intervention (0 W), after 12 weeks (12 W), and at follow-up (24 W). The following variables will be assessed: Child-Pugh classification; MELD score; SF-36 questionnaire; fatigue severity index; 6-min walk test; timed-up and go; 30-s sitting and rising test; dietary record; one-repetition maximum (1-RM) strength test (knee extension exercise); and vastus lateralis' cross-sectional area, Pennation angle, and fascicle length. The BFR-RT group will undergo 12 weeks of knee extension exercise (1 × 30 repetitions and 3 × 15 repetitions at 20% 1-RM and 50% of total blood flow occlusion pressure), with two sessions per week. Data normality will be assessed using the Shapiro-Wilk test. In case of normal distribution, a one-way repeated measures analysis of variance will be implemented to test for differences in baseline values. A mixed model then will be applied for each dependent variable. In case of non-normal data distribution, a Kruskal-Wallis test will be implemented to test for differences in baseline values. Next, the Friedman test will be used to analyze repeated measures. Within- and between-group effect sizes will be calculated using Cohen's d for each outcome. Finally, the minimal clinically important difference will be analyzed with distribution-based methods. DISCUSSION: To our knowledge, this will be the first trial to investigate BFR-RT in patients with cirrhosis and evaluate the effects on neuromuscular parameters, functional performance, disease severity, and quality of life outcomes. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (ReBec): RBR-395mfw. Registered on 25 August 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nóbrega SR, Chachá SGF, Libardi CA, et al. Resistance training combined with blood flow restriction in cirrhosis: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32471480. doi:10.1186/s13063-020-04410-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。